U.S. Liquid Biopsy Market Size, Share & Industry Analysis, By Product (Assay Kits & Consumables, and Instruments), By Application (Oncology, Non-Invasive Prenatal Testing (NIPT), and Others), By End User (Hospitals, Clinical Laboratories, and Others), and Country Forecast, 2024-2032

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI107914

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Cancer, 2023
2. Key Industry Developments - Mergers, Partnerships, & Acquisitions
3. Recent Product Launches, By Key Players
4. Impact of COVID-19 on the Market
U.S. Liquid Biopsy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Assay Kits & Consumables
  2. Instruments
2. Market Analysis, Insights and Forecast – By Application
  1. Non-invasive Prenatal Testing (NIPT)
  2. Oncology
  3. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Clinical Laboratories
  3. Others
Competitive Analysis
1. U.S. Market Share Analysis (2023)
2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
  1. Guardant Health
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  2. PERSONALIS, INC.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  3. FOUNDATION MEDICINE, INC.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  4. Natera, Inc.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  5. Illumina, Inc.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  6. F. Hoffmann-La Roche Ltd
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  7. Menarini Silicon Biosystems, Inc.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  8. Thermo Fisher Scientific Inc.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  9. QIAGEN
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  10. Bio-Rad Laboratories, Inc.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)